Autolus Therapeutics plc (AUTL) Corporate Subsidiaries
Autolus Therapeutics plc (AUTL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AUTL
CIK: 1730463
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 9/30/2017 12:00:00 AM
Lead Engagement PartnerAdrian Bennett
Audit LocationReading, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-09-22 | — | EFFECT Filing | 9999999995-26-003037 | View SEC Doc Filr Page |
| 424B3 | 2026-09-22 | — | 424B3 | 0001193125-26-398045 | View SEC Doc Filr Page |
| DEL AM | 2026-09-15 | — | DEL AM | 0001193125-26-391969 | View SEC Doc Filr Page |
| S-3 | 2026-09-14 | — | S-3 | 0001193125-26-389586 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | PRIMARY DOCUMENT | 0001730463-26-000131 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006649 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-28 | — | SCHEDULE 13D/A Filing | 0001213900-26-095283 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003552 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001730463-26-000123 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001730463-26-000119 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001730463-26-000112 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-30 | 8-K | 0001193125-26-329526 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000107 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000105 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000101 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000099 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000097 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000095 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000093 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | PRIMARY DOCUMENT | 0001730463-26-000091 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001730463-26-000072 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-05 | 8-K | 0001730463-26-000069 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001426156-26-000009 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002127 | View SEC Doc Filr Page |